Japan-based Fujikura Kasei will exercise its option to licence the midkine (MK) diagnostic technology and will make a JPY40 million ($403,000) payment as milestone fee to Australia-based Cellmid. The companies signed the option to license ...
Aptiv Solutions, a US-based medical device and biopharmaceutical company, has introduced AptivInSite, a new adaptive monitoring methodology. Developed for medical device companies, AptivInSite helps in maximising trial efficiency while ...
Tags: Health, Medicine, biopharmaceutical
Danish healthcare company Radiometer Medical has purchased Quest Diagnostics' HemoCue diagnostic products business for $300m plus customary adjustments for cash balances. Quest will use the proceeds to repurchase approximately $300m of ...
Australian biotechnology company Cellmid has entered into an option agreement with Japanese company Fujikura Kasei. Under the option to license agreement, Cellmid will supply its proprietary anti-midkine diagnostic antibodies for ...
Tags: Cellmid, Fujikura Kasei, anti-midkine diagnostic antibodies
Life science research and clinical diagnostic products manufacturer Bio-Rad Laboratories has acquired AbD Serotec, a division of MorphoSys. Under the transaction, Bio-Rad paid euro 53m in cash to AbD Serotec, which offers over 15,000 ...
Tags: clinical diagnostic products, Bio-Rad Laboratories, AbD Serotec
Reedy Acquisitions has agreed to buy South Carolina-based laboratory operations of Lab21,which provides diagnostic products and services. Supporting blood bank screening,medical diagnostics and drug discovery services,Lab21's products ...
Tags: Reedy Acquisitions, financial details, blood bank screening
Volition has announced a new collaboration with the Wales Cancer Bank,with the two businesses set to carry out an internal clinical study for the Nucleosomics diagnostic products. At the end of this month,tests will be carried out on ...
Tags: Volition, Wales Cancer Bank, Nucleosomics diagnostic products
Bio-Rad Laboratories, a provider of clinical diagnostic products, has purchased Propel Labs' automated sorting flow cytometer. Under the agreement, Bio-Rad will name the new cell sorting system as the S3 Cell Sorter which will provide ...
The European Union has granted CE mark to Abacus Diagnostica's molecular diagnostic assay, designed for detecting toxin-producing Clostridium difficile. The GenomEra C. difficile assay, which is designed for use with the company's ...
Prometheus Laboratories, a developer of diagnostic products, has introduced new Prometheus Anser infliximab (IFX) monitoring test. By utilizing the company's proprietary homogenous mobility shift assay (HMSA), the test measures infliximab ...
Tags: Prometheus, IFX, monitoring test, HMSA, IBD
Bio-Rad Laboratories has entered into an agreement to purchase a division of MorphoSys, AbD Serotec, for euro 53m. The deal, which is anticipated to complete in January 2013, is subject to certain closing conditions. Bio-Rad life ...
Tags: Bio Rad, Abd Serotec, antibodies, cell sorting
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
Novation has awarded a two year supplier agreement to a manufacturer of in vitro diagnostic products, Hycor Biomedical. Under the agreement, Hycor will provide more than 65,000 members served by Novation including VHA, UHC, two national ...